Happi Staff12.18.20
Gattefossé is investing €30 million in its industrial operations and will build a new manufacturing plant in Lufkin, TX that produce lipid based specialty ingredients for the personal care and pharmaceutical industries.
This new production site will deepen the company’s presence in North America to better meet local customers’ needs and increase its global production capacity. The facilitu will laos provide back-up solutions on three continents and bring more supply flexibility to all customers, said Gattefossé.
Construction will begin in 2021 and the plant should deliver its first customers in 2024.
“North America is a leading region for the global pharmaceutical and personal care industries in terms of innovation, production and consumption, and has therefore a major impact on worldwide trends. The opening of a manufacturing unit represents an essential milestone in our strategy to enhance our local presence and commitment to this important and influential market," said Eric Brun, president and CEO of Gattefossé USA and Canada. "The label "Made in USA" will satisfy a strong demand expressed by our customers and the geographical location of this new site will facilitate logistics and supply chain. Production in Texas is first intended to serve the North American market but will gradually be extended to other regions,”
Gattefossé Group currently operates two production sites—in France and Singapore.
The company chose Lufkin for its central position in North America and its proximity to Houston.
“The international expansion of industrial operations is an essential step in the development of our Group. This project meets the economic and environmental challenges set by the company as part of its global strategy: innovation, customer intimacy, geographic expansion and social responsibility. Controlling our environmental impact is a priority: Gattefossé headquarters will be ISO 14001 certified in 2021 and the new American site will also meet this requirement,” said Eduardo De Purgly, Gattefossé Group CEO.
This new production site will deepen the company’s presence in North America to better meet local customers’ needs and increase its global production capacity. The facilitu will laos provide back-up solutions on three continents and bring more supply flexibility to all customers, said Gattefossé.
Construction will begin in 2021 and the plant should deliver its first customers in 2024.
“North America is a leading region for the global pharmaceutical and personal care industries in terms of innovation, production and consumption, and has therefore a major impact on worldwide trends. The opening of a manufacturing unit represents an essential milestone in our strategy to enhance our local presence and commitment to this important and influential market," said Eric Brun, president and CEO of Gattefossé USA and Canada. "The label "Made in USA" will satisfy a strong demand expressed by our customers and the geographical location of this new site will facilitate logistics and supply chain. Production in Texas is first intended to serve the North American market but will gradually be extended to other regions,”
Gattefossé Group currently operates two production sites—in France and Singapore.
The company chose Lufkin for its central position in North America and its proximity to Houston.
“The international expansion of industrial operations is an essential step in the development of our Group. This project meets the economic and environmental challenges set by the company as part of its global strategy: innovation, customer intimacy, geographic expansion and social responsibility. Controlling our environmental impact is a priority: Gattefossé headquarters will be ISO 14001 certified in 2021 and the new American site will also meet this requirement,” said Eduardo De Purgly, Gattefossé Group CEO.
